Global AIDS head to address healthcare conference April 24 | News | Notre Dame News | University of Notre Dame Skip To Content Skip To Navigation Skip To Search University of Notre Dame Notre Dame News Experts ND in the News Subscribe About Us Home Contact Search Menu Home › News › Global AIDS head to address healthcare conference April 24 Global AIDS head to address healthcare conference April 24 Published: April 18, 2005 Author: Erik Runyon Ambassador Randall Tobias, the U.S. Global AIDS Coordinator, will deliver the keynote address at8 p.m.Sunday (April24) at a conference examining healthcare in developing countries at the University of Notre Dame. The talk will take place in the atrium of the Mendoza College of Business and is free and open to the public. TitledQuality Healthcare in Developing Countries: Sustainability, The New Imperative,the conference has been convened by Notre Dames Center for Ethics and Religious Values in Business and its Program on Multinational Managers and Developing Country Concerns. During the conference, leaders in non-governmental and faith-based organizations will discuss how to be more effective in delivering health care to the poor who suffer from HIV/AIDS, malaria and other serious illnesses. During the past 20 years, AIDS in sub-SaharanAfricahas taken nearly 20 million lives, and today almost one in five people in the region are infected by the HIV retrovirus. Appointed to his post in October 2003, Tobias is responsible for overseeing allU.S.international HIV/AIDS assistance and coordinating the efforts of the various agencies and departments of theU.S.government that deliver it. Prior to entering government service, Tobias was chairman, president and chief executive officer of Eli Lilly and Company. The conference also will feature a presentation by South African Bishop Kevin Dowling, chair of the Justice and Peace Commission of the Southern Africa Catholic Bishops Conference, at9:15 a.m.Monday (April 25) in McKenna Hall. Joining the leaders of non-government organizations from developing countries will be leading scholars in the field and representatives from major pharmaceutical companies. The conference has been made possible by funding from Abbott, Bristol-Myers Squibb, Eli Lilly, F. Hoffmann-La Roche Ltd., Johnson&Johnson, Merck, and Pfizer. More information is available at 574-631-6072 or coch.1@nd.edu . TopicID: 10827 Home Experts ND in the News Subscribe About Us For the Media Contact Office of Public Affairs and Communications Notre Dame News 500 Grace Hall Notre Dame, IN 46556 USA Facebook Twitter Instagram YouTube Pinterest © 2022 University of Notre Dame Search Mobile App News Events Visit Accessibility Facebook Twitter Instagram YouTube LinkedIn